B of A Securities Maintains Neutral on Navient, Lowers Price Target to $16

+2.38% Pre

Navient

NAVI

0.00

B of A Securities analyst Nathaniel Richam-Odoi maintains Navient (NASDAQ: NAVI) with a Neutral and lowers the price target from $17 to $16.

More This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.

Recommend

How Vaxcyte's (PCVX) $1 Billion Thermo Fisher Deal Could Shape Its US Vaccine Supply Chain

ZenaTech (ZENA) Is Up 13.4% After Unveiling Quantum Hardware to Power AI Drones for Defense

How Investors May Respond To United Airlines Holdings (UAL) New Transatlantic Routes and Expanded Summer 2026 Schedule

The Bull Case for Las Vegas Sands (LVS) Could Change Following Digital Exit and Big Resort Expansion Announcement

Should DigitalOcean's AI Ecosystem Expansion Prompt New Thinking From DOCN Investors?

Stock Ratings | Citigroup maintained a "buy" rating on Arcus Biosciences (RCUS) and raised its price target from $47 to $54.

US Market Preview | GWAV Surges 101.8%; US-CN Spats Escalate, Techs Lead Drop; Powell Speech Awaited

Financial Morning Summary | PIF Assets Jump 42% to SAR 206.2B; RETAL(4322) Wins SAR 461.9M ROSHN Contract; IMF Projects 4% Saudi Growth